A group of UK researchers, leading biopharmaceutical companies and industry groups have called on the country's National Health Service to take a dramatic step forward by introducing genetic profiling of every patient's cancer following diagnosis and during treatment.
-
Latest News
Critical decisions over two months and four sitting weeks
The industry has already engaged political stakeholders on the impact of the new PBS pricing framework but it is likely to get more intense in October and November with major decisions and four critical sitting weeks of the parliament.
-
Latest News UK push to lead the world on genetic profiling of cancer patients August 11, 2022
-
Latest News MSD in new agreement with Australian company Starpharma August 11, 2022Starpharma has announced a new research agreement under which it will design and synthesise a number of DEP dendrimer conjugates and provide them to MSD.
-
Latest News BIO says 'fewer cures' the only certain outcome of price controls August 11, 2022BIO president and CEO Dr Michelle McMurry-Heath said the only certain outcome from the change will be "fewer cures for patients."
-
Latest News Companies hit hard by the new price cut 'flow on' mechanism August 10, 2022The industry is significantly focused on the implications of next April's 'catch-up' statutory price reductions but it might need to take a wider view of what are much broader and fundamental changes to the policy infrastructure of the PBS that will have an enduring impact.
-
Latest News An outcome that 'disadvantages' the respondent is not relevant August 10, 2022The hearing's presiding officer challenged the line of questioning, saying an outcome that 'disadvantages' the Commonwealth is not relevant to the hearing or Freedom of Information laws.
-
Latest News PAIG announces ‘Pay it forward’ session as part of new look program August 10, 2022The Pharma Australia Inclusion Group has launched a new ‘pay it forward’ initiative at yesterday's first workshop of its 2022-23 diversity and inclusion program.
-
Latest News TGA registration for Roche's innovative eye therapy August 10, 2022The TGA has registered Roche's eye therapy VABYSMO (faricimab) for the treatment of neovascular or 'wet' age-related macular degeneration and diabetic macular oedema.
-
Latest News Victoria’s first mRNA innovation hub backed by state government August 10, 2022The Victorian government has provided $5.4 million to a collaboration involving researchers from Monash University and the University of Melbourne to establish the state's mRNA Innovation Hub.
-
Latest News Counsel accuses Commonwealth witnesses of 'evasive' responses to questions August 9, 2022The first day of a critical legal hearing has seen more information revealed about the process concerning the consideration of funding for a breast cancer tumour profiling test but the suggestion witnesses were being evasive.
-
Latest News What other government records are officials destroying? August 9, 2022One staggering admission at yesterday's Administrative Appeals Tribunal hearing was from Professor Robyn Ward on the process for the destruction of documents.
-
Latest News Industry says backing for US pricing reform a 'tragic loss for patients' August 9, 2022The US research-based pharmaceutical industry has slammed Senate endorsement of the Biden administration's plan that allows the government to negotiate and set prices for some prescription medicines.
-
Latest News Blood Cancer Taskforce launches optimal care pathways August 9, 2022Australia’s Blood Cancer Taskforce has launched six new Optimal Care Pathways for blood treatment and care.
-
Latest News Sanofi starts installing solar panels at manufacturing facility August 9, 2022Sanofi Australia has started the process of installing a system of over 1,500 solar panels across its Brisbane manufacturing site.
-
Latest News Mark Butler must be very confused by this situation August 7, 2022It is an incredibly embarrassing situation for an industry trying to establish a working relationship with a new government but it could get worse given what else could be lurking in these agreements and the fact the exercise of 'discretion' will come with a cost.
-
Latest News What needs to change to ensure this never happens again? August 8, 2022The evidence suggests the industry simply does not understand the mechanics and inner workings of the institutionalised policy environment in which it operates.
-
Latest News The result of a process that started badly and only got worse August 8, 2022In mid-2020, in the months leading up to the 2020-21 Budget, former health minister Greg Hunt invited the industry's two main associations to start the negotiation for new agreements to follow those that were due to expire in mid-2022. The offer was clearly a trap.
-
Latest News Department switches excuse to block release of a simple number August 5, 2022The number of applications seeking the exercise of ministerial discretion to vary or waive next April's 'catch-up' reductions needs to be made public as a matter of principle given the potential implications for a critical public health program.
-
Latest News 'Rapid review' of Budget decision has been nothing if not rapid August 4, 2022The federal government's 'rapid review' of its predecessor's decision to defund NPS Medicinewise as the steward of the QUM arm of the National Medicines Policy has been nothing if not rapid.
-
Latest News 'Green whistle' maker announces capital raise and sales growth August 4, 2022The Australian maker of the rapid onset painkiller known as the 'green whistle' has announced a significant capital raise it will use to fund its growth and expansion.
Australian Biotech
-
First patient enrolled in new trial of NovoSorb SynPath treatment
August 11, 2022 -
Partrys' candidate in combination improves survival in brain cancer model
August 11, 2022 -
Dimerix announces new patent family for DMX-700
August 9, 2022 -
Telix and UQ-led consortium awarded Australian Research Council grant
August 9, 2022 -
Neuren commences enrolment new Phase 2 trials of NNZ-2591
August 9, 2022
Other Health
-
Scrapped COVIDSafe app only identified two positive cases
August 11, 2022 -
Compare the Market investor moves to acquire all of iSelect
August 11, 2022 -
New report promotes expansion of short-stay hospital program
August 11, 2022 -
Helping doctors reduce out-of-pocket expenses for patients
August 9, 2022 -
HCF and Ramsay announce collaboration to develop new care models
August 9, 2022
Latest Video
New Stories
-
First patient enrolled in new trial of NovoSorb SynPath treatment
August 11, 2022 - - Australian Biotech -
Partrys' candidate in combination improves survival in brain cancer model
August 11, 2022 - - Australian Biotech -
Scrapped COVIDSafe app only identified two positive cases
August 11, 2022 - - Other Health -
Compare the Market investor moves to acquire all of iSelect
August 11, 2022 - - Other Health -
New report promotes expansion of short-stay hospital program
August 11, 2022 - - Other Health -
Critical decisions over two months and four sitting weeks
August 11, 2022 - - Latest News -
UK push to lead the world on genetic profiling of cancer patients
August 11, 2022 - - Latest News